Revenue: The sum of all revenue fields included for a company's operating activities.
Boston Scientific Corporation (BSX) had Revenue of $4.66B for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$4.66B |
$674.00M |
|
$1.45B |
|
$3.21B |
|
$3.74B |
|
$922.00M |
|
$-116.00M |
|
$805.00M |
|
$805.00M |
|
$672.00M |
|
$672.00M |
|
$672.00M |
|
$672.00M |
|
$922.00M |
|
$1.25B |
|
1.48B |
|
1.49B |
|
$0.46 |
|
$0.45 |
|
| Balance Sheet Financials | |
$7.33B |
|
$3.39B |
|
$32.80B |
|
$40.14B |
|
$5.06B |
|
$10.53B |
|
$12.64B |
|
$17.69B |
|
$22.45B |
|
$-1.46B |
|
$22.45B |
|
1.48B |
|
| Cash Flow Statement Financials | |
$541.00M |
|
$-500.00M |
|
$233.00M |
|
$606.00M |
|
$919.00M |
|
$314.00M |
|
$74.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.45 |
|
-- |
|
-- |
|
0.32 |
|
0.50 |
|
68.84% |
|
19.77% |
|
19.77% |
|
-- |
|
17.26% |
|
14.45% |
|
$354.00M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.51 |
|
1.73 |
|
51.98 |
|
2.99% |
|
-46.03% |
|
1.67% |
|
2.04% |
|
$15.17 |
|
$0.24 |
|
$0.36 |
|